Skip to main content
. 2025 Nov 21;16:1688090. doi: 10.3389/fimmu.2025.1688090
Day 30 CD3+CD8+ T cells
Predictor Beta (Unstd.) SE Beta (Std.) 95% CI (lower, upper) p-value
Intercept 1,434.38 721.98 −421.52, 3,290.28 0.104
Sexa 182.05 152.43 0.464 −209.79, 573.89 0.286
Age at ublituximab start, years −13.22 7.12 −0.789 −31.51, 5.07 0.122
BMI (kg/m2) −15.17 24.90 −0.241 −79.17, 48.82 0.569
No. of previous DMTs −34.85 56.35 −0.220 −179.71, 110.01 0.563
Gadolinium-enhancing lesions at baseline MRI −98.88 205.60 −0.202 −627.40, 429.65 0.651

Model statistics: R² = 0.481; adjusted R² = −0.037; F(5, 5) = 0.93; p = 0.532.